Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Other financing activities (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Other financing activities for 6 consecutive years, with $1.0 million as the latest value for Q1 2025.

  • On a quarterly basis, Other financing activities rose 13.92% to $1.0 million in Q1 2025 year-over-year; TTM through Sep 2025 was $1.0 million, a 13.92% increase, with the full-year FY2024 number at $905000.0, changed N/A from a year prior.
  • Other financing activities was $1.0 million for Q1 2025 at Precision Biosciences, up from $905000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $35.0 million in Q1 2021 to a low of -$35.0 million in Q3 2021.
  • A 3-year average of $487250.0 and a median of $968000.0 in 2024 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: soared 25447.45% in 2021, then rose 13.92% in 2025.
  • Precision Biosciences' Other financing activities stood at -$35.0 million in 2021, then soared by 102.59% to $905000.0 in 2024, then grew by 13.92% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Other financing activities are $1.0 million (Q1 2025), $905000.0 (Q1 2024), and -$35.0 million (Q3 2021).